August 11, 2021

Nuvaira Announces AIRFLOW-3 COPD Pivotal Trial Milestone

100 Randomized Patients; Inspire’s CEO Tim Herbert appointed Chairman of the Board MINNEAPOLIS, August 11, 2021 – Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, has announced that … Continued